Skip to content
Peptidepedia

BPC-157 Dosage Guide: Protocols, Timing & How Much to Take (2026)

From Peptidepedia, the trusted peptide wiki.

Dosage Protocols

Since BPC-157 is not FDA-approved for human use, there are no officially established dosing guidelines. The following information reflects dosages commonly reported in research literature and anecdotal use.

Standard Dosing Range:

  • Low dose: 200 to 250 mcg once daily
  • Moderate dose: 250 to 500 mcg once or twice daily
  • Higher dose: 500 to 800 mcg once or twice daily

Weight-Based Dosing: Based on animal study extrapolations, an estimated human equivalent dose is approximately 1.6 mcg/kg body weight, translating to roughly 110 mcg for a 150-pound person and 145 mcg for a 200-pound person when using oral administration.

Cycling Guidelines:

  • Typical cycle length: 4 to 8 weeks
  • Some users employ 4 weeks on, 2 to 4 weeks off protocols
  • For acute injuries, shorter cycles of 2 to 4 weeks may be utilized
  • Chronic conditions may warrant longer cycles under appropriate guidance
In preclinical safety studies, no toxic or lethal dose was achieved across a wide range of doses from 6 μg/kg to 20 mg/kg, suggesting a favorable safety margin.

Frequently Asked Questions

Preclinical animal studies have shown no acute toxicity across multiple organ systems at various doses over 6-week periods. However, human clinical safety data are essentially nonexistent. The FDA has expressed concerns about potential immunogenicity and unknown long-term effects. Additionally, unregulated manufacturing creates contamination risks.

Lyophilized (powder) BPC-157 should be stored below -18°C for long-term storage, though it remains stable at room temperature for approximately 3 weeks. Once reconstituted with bacteriostatic water, store at 2 to 8°C (refrigerator) and use within 4 weeks. Protect from light and avoid freeze-thaw cycles.

This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

References

  1. Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025.
  2. Sikiric P, et al. Multifunctionality and Possible Medical Application of the Pentadecapeptide BPC 157. Pharmaceuticals. 2025.
  3. Chang CH, et al. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014.
  4. Examine.com. BPC-157: Research Breakdown.
  5. U.S. Anti-Doping Agency. BPC-157: Experimental Peptide Creates Risk for Athletes.
  6. World Anti-Doping Agency. The 2024 Prohibited List International Standard.
  7. ClinicalTrials.gov. PCO-02 - Safety and Pharmacokinetics Trial.
  8. Rupa Health. BPC 157: Science-Backed Uses, Benefits, Dosage, and Safety.
  9. Drip Hydration. The Wolverine Stack: Can BPC 157 and TB 500 Accelerate Injury Recovery?
  10. Preferred Regenerative Medicine. The BPC-157, TB-500, KPV & GHK-Cu Peptide Stack Guide.
  11. Sikiric P, et al. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy. PubMed.
  12. Sikiric P, et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide, Literature and Patent Review. PubMed.
←Read the full BPC-157 guide

“Peptidepedia compiles and maintains peptide information from peer-reviewed research, clinical trials, and verified laboratory data.”